Your Medical Team for Pituitary Disorders
Our physician specialists at University of Colorado Hospital provide you with multidisciplinary care and support during treatment for your pituitary disorder.
Pituitary Specialists
Margaret E. Wierman, MD

Dr. Wierman received her MD and residency training at at Baylor College of Medicine. Her fellowship and research training was at Massachusetts General Hospital and the Brigham and Women’s Hospital at Harvard University. She has been a faculty member at the University of Colorado since 1987 and her expertise is in reproductive and neuroendocrinology. Dr. Wierman’s research interests are in the regulation of the genes that control the reproductive axis. Collaborative projects with other investigators at the University of Colorado Health Sciences Center include the role of sex hormones in body weight distribution at menopause and sex hormone effects on HIV transmission and progression in women.
Janice Kerr, MD
Dr. Kerr joined the faculty of the Division of Endocrinology, Metabolism and Diabetes in July 2006. She received a B.S. degree in Chemistry at the California Polytechnic State Institute in 1987. Following several adventurous years in biotechnology research, she obtained her M.D. degree at the University of California, Irvine in 1997. She then completed her internship and residency in Internal Medicine, at the University of Colorado Health Sciences Center, followed by a fellowship training in Endocrinology. She is board certified in both Internal Medicine and Endocrinology. Dr. Kerr serves as the co-director of the Pituitary Program at the University of Colorado, Denver, where she works as part of a multi-disciplinary team to provide comprehensive care to patients with pituitary disorders. Her clinical research interests include novel therapeutics for patients with Cushing's Disease and Acromegaly.
Virginia Sarapura, MD

Dr. Sarapura joined our faculty in 1992, following a fellowship in endocrinology at this institution. Her clinical interests are pituitary and thyroid disease, particularly the disorders of prolactin secretion, pituitary tumors, and abnormal thyroid function. Her research interests are in the area of pituitary gene expression and regulation.
E. Chester Ridgway, MD

Dr. Ridgway came to Colorado in 1985 from the Massachusetts General Hospital in Boston Massachusetts where he was head of the Thyroid Unit to become Head of the Division of Endocrinology, Metabolism, and Diabetes (1985-2007). He is the past President of the American Thyroid Association (1996-97) and past President of the Endocrine Society (2003-2004). Based at the University of Colorado Health Sciences Center, his basic research centers on thyrotropin (TSH), the major regulator of the thyroid gland. Dr. Ridgway's laboratory has a long interest in the production of the glycoprotein pituitary hormones by pituitary tumors.